参考文献/References:
[1] Clark AM,Ma B,Taylor DL,et al.Liver metastases:Microenvironments and ex-vivo models[J].Exp Biol Med(Maywood),2016,241(15):1639-1652.
[2] 蒋益兰,潘敏求,黄 钢.原发性肝癌中西医结合诊疗专家共识[J].中医药导报,2021,27(9):101-107.
[3] 文良志,肖 潇,颜綦先,等.肝细胞癌血管介入治疗临床研究新认知[J].临床肝胆病杂志,2021,37(8):1761-1764.
[4] Sieghart W,Hucke F,Radosavljevic M.Transarterial chemoembolization:Modalities,indication,and patient selection[J].J Hepatol,2015,62(5):1187-1195.
[5] 李 珣,张祥林.肝动脉化疗栓塞联合恩替卡韦对原发性肝癌治疗效果及对患者血清中恶性肿瘤特异性生长因子的影响[J].陕西医学杂志,2019,48(7):873-875.
[6] Qi JL,Min KH,Huan WC,et al.Hepatic arterial infusion of oxaliplatin,fluorouracil,and leucovorin versus transarterial chemoembolization for large hepatocellular carcinoma:A randomized phase Ⅲ trial[J].J Clin Oncol,2021(14):2100608.
[7] 孙惠川,谢 青,荚卫东,等.肝癌转化治疗中国专家共识(2021版)[J].中国实用外科杂志,2021,41(6):618-632.
[8] 周仲瑛,吴勉华,周学平,等.中医辨治肿瘤十法[J].南京中医药大学学报,2018,34(6):541-548.
[9] 林丽珠,肖志伟,杨才志.原发性肝癌的全程规范管理及中西医治疗策略[J].中西医结合肝病杂志,2020,30(2):97-99,110.
[10] 钱程欣,李嘉旗,周 迪.化疗所致血小板减少的中西医治疗进展[J].中医肿瘤学杂志,2021,3(5):57-62.
[11] 苏凯奇,林柳兵,陈懿榕,等.中医药在肝癌介入术后的临床应用现状[J].吉林中医药,2018,38(12):1480-1483.
[12] 赵若含,李慧杰,李秀荣.中医药防治化疗后胃肠道反应的概况[J].中国中西医结合消化杂志,2021,29(10):749-752.
[13] 季锡林.中药方剂缓解肝癌介入后症状的临床观察[J].光明中医,2020,35(2):217-219.
[14] 范文轩,王三虎,黄 瑞,等.四磨汤口服液治疗原发性肝癌介入化疗栓塞术后胃肠功能障碍41例临床观察[J].中国中西医结合消化杂志,2016,24(8):632-633.
[15] 陆海燕,杨 玚,孟志强,等.姜末穴位外敷预防含铂化疗药物介入治疗肝癌及转移性肝癌后恶心呕吐的研究[J].介入放射学杂志,2010,19(8):664-668.
[16] 唐 耀,廖冬颖,宋金鸣,等.紫杉醇类化疗药物导致骨髓抑制的中医药防治进展[J].陕西中医,2021,42(12):1822-1824.
[17] 冯娅清,魏 晔,武佩瑶.益气扶正汤口服对原发性肝癌介入术后不良反应及生活质量的影响[J].中国中医药科技,2020,27(2):261-263.
[18] 韩伍龙,袁春樱,张婷素.复方苦参注射液联合介入化疗治疗原发性肝癌的疗效观察及其对免疫功能的影响[J].中国中医药科技,2012,19(1):61-62.
[19] 李 丹,赵 飞,王树庚.疏肝健脾散结汤联合肝动脉插管化疗栓塞术治疗原发性肝癌疗效研究[J].陕西中医,2021,42(6):728-731.
[20] 琚 洁,陈倚天.清热解毒方联合洛铂介入栓塞治疗原发性肝癌临床研究[J].新中医,2021,53(13):122-126.
[21] 寇小妮,郝明霞,解新科,等.八珍汤在原发性肝癌介入治疗后的应用[J].现代肿瘤医学,2016,24(18):2920-2922.
[22] 陈敏山,元云飞,郭荣平,等.肝动脉灌注化疗在肝癌转化治疗中的应用——中山大学肿瘤防治中心的经验总结[J].中国医学前沿杂志:电子版,2021,13(3):70-76.
[23] 闫芍药,聂会勇,王锁良.加味双柏散外敷联合耳穴压豆对肝癌介入治疗患者疼痛评分及生活质量影响[J].陕西中医,2020,41(12):1763-1766.
[24] 徐晓婉,翟笑枫,李小燕.止痛消结散外敷减轻老年肝癌患者介入术后肝区疼痛的疗效观察[J].老年医学与保健,2021,27(4):748-751.
[25] 于 贺.柴胡桂枝汤治疗原发性肝癌介入术后综合征临床研究[D].郑州:河南中医药大学,2018.
[26] 王静娜.补益消癥方治疗原发性肝癌介入术后并发症的疗效观察[D].广州:广州中医药大学,2018.
[27] 张 妮.三金柴疏散联合肝动脉灌注化疗治疗中晚期肝癌的临床疗效[J].中西医结合肝病杂志,2020,30(2):164-165.
[28] 钟佑衡,吴 斌,韩 杲.中医养阴清毒法结合肝动脉介入术治疗原发性肝癌的疗效观察[J].现代诊断与治疗,2021,32(6):854-855.
[29] 张玉萍,李婵桂,邹 莹.黄芪四君子汤联合成分输血对肝癌介入术后免疫功能影响的研究[J].新中医,2020,52(9):46-48.
[30] 王 娟,谢建芝.分析在肿瘤介入治疗患者中情志护理的效果分析[J].现代医学与健康研究电子杂志,2018,2(18):187,197.
相似文献/References:
[1]肖 岚,朱 宏,张 婷,等.董克礼教授治疗原发性肝癌临床经验*[J].陕西中医,2020,(11):1639.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.032]
XIAO Lan,ZHU Hong,ZHANG Ting,et al.Experience of professor DONG Keli for treating primary liver cancer[J].,2020,(5):1639.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.032]
[2]王 军,徐建良,杜燕红.扶正祛邪汤对肝癌模型大鼠肠道菌群微生态环境的作用研究[J].陕西中医,2021,(2):143.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.002]
WANG Jun,XU Jianliang,DU Yanhong.Effect of Fuzheng Quxie decoction on intestinal microflora microecological environment of liver cancer model rats[J].,2021,(5):143.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.002]
[3]朱玉辉,柴 劲.黄芪补气汤联合还原型谷胱甘肽对肝癌介入治疗后患者肝功能、氧化应激及炎症的影响[J].陕西中医,2021,(5):570.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.006]
ZHU Yuhui,CHAI Jin.Effect of Huangqi Buqi decoction combined with reduced glutathione on liver function,oxidative stress and inflammation after interventional therapy for hepatocellular carcinoma[J].,2021,(5):570.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.006]
[4]刘振方,孙巧玉,孟祥彩,等.黄芩素下调微小RNA-130a抑制肝癌细胞侵袭机制研究[J].陕西中医,2021,(12):1667.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.003]
LIU Zhenfang,SUN Qiaoyu,MENG Xiangcai,et al.Study on mechanism of baicalein down-regulating miR-130a to inhibit hepatocellular carcinoma invasion[J].,2021,(5):1667.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.003]
[5]陈 嵘,李淑敏,李旭华,等.软坚散结方调控小鼠HIF-1α 糖酵解分子转导抑制肝肿瘤细胞增殖机制研究[J].陕西中医,2023,(7):839.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.003]
CHEN Rong,LI Shumin,LI Xuhua,et al.Mechanism study on Ruanjian Sanjie prescription inhibit proliferation of liver cancer cells through regulating HIF-1α pathway[J].,2023,(5):839.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.003]
[6]刘 鹏,陈青山,杨建波.柴胡疏肝散加减联合射频消融治疗肝癌疗效研究[J].陕西中医,2023,(7):892.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.015]
LIU Peng,CHEN Qingshan,YANG Jianbo.Curative effect study on Chaihu Shugan powder combined with radiofrequency ablation for liver cancer[J].,2023,(5):892.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.015]
[7]张宏生,林月洁,陆凤娟.血府逐瘀汤加减联合盐酸吗啡缓释片治疗肝癌疼痛瘀血内阻证疗效研究[J].陕西中医,2023,(7):897.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.016]
ZHANG Hongsheng,LIN Yuejie,LU Fengjuan.Clinical study on modified Xuefu Zhuyu decoction supplemented with morphine hydrochloride sustained-release tablets in treatment of liver cancer pain of Yuxue Neizu syndrome[J].,2023,(5):897.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.016]
[8]孔庆旭,陈桂云,陈自力,等.槲芪方加减对肝癌化疗栓塞术后大鼠一氧化氮合酶、血管内皮生长因子、乏氧及免疫功能的影响[J].陕西中医,2024,(2):181.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.007]
KONG Qingxu,CHEN Guiyun,CHEN Zili,et al.Effects of Huqi formula on iNOS,VEGF,hypoxia and immune function of rats after chemoembolization for liver cancer[J].,2024,(5):181.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.007]
[9]郭桓博,马瑞雪,朱正望,等.中药基于铁死亡机制防治肝癌研究进展[J].陕西中医,2024,(2):282.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.030]
GUO Huanbo,MA Ruixue,ZHU Zhengwang,et al.Research progress in the prevention and treatment of liver cancer based on the mechanism of iron osis in traditional Chinese medicine[J].,2024,(5):282.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.030]
[10]李杳瑶,刘 华,孙铜林,等.鳖甲煎丸对肝癌大鼠黏着斑激酶/雷帕霉素靶蛋白通路的影响[J].陕西中医,2024,(3):308.[doi:DOI:10.3969/j.issn.1000-7369.2024.03.004]
LI Yaoyao,LIU Hua,SUN Tonglin,et al.Effects of Biejia Jianwan on liver histopathological features and FAK/mTORC1 pathway in rats with hepatocellular carcinoma[J].,2024,(5):308.[doi:DOI:10.3969/j.issn.1000-7369.2024.03.004]